Plasma exchange and immunoadsorption for autoimmune neurologic diseases - current guidelines and future perspectives

Atherosclerosis Supplements

Volumn 10, Issue 5, 2009, Pages 129-132

  Klingel, Reinhard ^a   Heibges, Andreas ^a   Fassbender, Cordula ^a  

^a Apheresis Research Institute   (Germany)

Author keywords

Guillain barr syndrome; Immunoadsorption; Multiple sclerosis; Myasthenia gravis; Plasma exchange

Indexed keywords

AUTOANTIBODY; BETA INTERFERON; CHOLINERGIC RECEPTOR ANTIBODY; CORTICOSTEROID; GANGLIOSIDE ANTIBODY; GLATIRAMER; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; METHYLPREDNISOLONE; MITOXANTRONE; NATALIZUMAB;

ALLERGY; ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; DISEASE SEVERITY; DRUG COST; DRUG MEGADOSE; GERMANY; GUILLAIN BARRE SYNDROME; HUMAN; HYPOCOAGULABILITY; IMMUNOADSORPTION; IMMUNOMODULATION; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; PATHOGENESIS; PLASMAPHERESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; THERAPY EFFECT; TREATMENT RESPONSE;

AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; BLOOD COMPONENT REMOVAL; HUMANS; IMMUNOSORBENT TECHNIQUES; PATIENT SELECTION; PLASMA EXCHANGE; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME;

EID: 72649095006     PISSN: 15675688     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5688(09)71827-6     Document Type: Article

References (19)

1. Diener HC and Putzki N (eds.) for the German Society for Neurology. Guidelines for Diagnosis and Therapy in Neurology (Leitlinien für die Diagnostik und Therapie in der Neurologie). Georg Thieme Publishers, Stuttgart 2008 and www.dgn.de.
2. Goldammer A., Derfler K., Herkner K., Bradwell A.R., Hoerl W., and Haas M. Influence of plasma immunoglobulin level on antibody synthesis. Blood 100 (2002) 353-355
3. Grob D., Simpson D., Mitsumoto H., Hoch B., Mokhtarian F., Bender F., Greenberg M., Koo A., and Nakayama S. Treatment of myasthenia gravis by immunoadsorption of plasma. Neurology 45 (1995) 338-344
4. Koehler W, Bucka C, Klingel R. A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis. eSubmitted for publication.
5. Gold R., Krenzer M., Klinker E., Mansouri B., Schneider-Gold C., Müllges W., Boeck M., and Toyka K.V. Efficacy and safety of immuno- adsorption vs plasmapheresis vs combination for treatment of myasthenic crisis: comparative retrospective study on 72 Patients. American Acad Neurol, 2008 annual meeting abstracts. http://www.abstracts2view.com/aan2008chicago
6. Wagner S., Janzen R.W.C., Mohs C., Pohlmann S., Klingel R., and Grützmacher P.W. Long-term treatment of refractory myasthenia gravis with immunoadsorption. Dtsch Med Wschr 133 (2008) 2377-2382
7. Haas M., Mayr N., Zeitlhöfer J., Goldammer A., and Derfler K. Long-term treatment of myasthenia gravis with immunoadsorption. J Clin Apheresis 17 (2002) 84-87
8. Goto H., Tujino A., Fujishita S., and Shibuya N. Tryptophan-PVA gel effectively removes antibodies against gangliosides. Jap J Apheresis 13 (1994) 164-165
9. Galldiks N., Dohmen C., Neveling M., Fink G.R., and Haupt W.F. Selective immune adsorption treatment of severe Guillain-Barré-syndrome in the intensive care unit. Neurocrit Care (2009 Jul 30) [epub ahead of print].
10. Hughes R., Donofrio P., Bril V., Dalakas M.C., Deng C., Hanna K., Hartung H.P., Latov N., Merkies I., and van Doorn P.A. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculopathy (ICE-study): a randomized placebo-controlled trial. Lancet Neurol 7 (2008) 136-144
11. Zinman L.H., Sutton D., Ng E., Nwe P., Ngo M., and Bril V. A pilot study to compare the use of the Excorim staphylococcal protein immuno- adsorption system and IVIG in chronic inflammatory demyelinating polyneuropathy. Transfus Apher Sci 33 (2005) 317-324
12. Noseworthy J.H., Lucchinetti C., Rodriguez M., and Weinshenker B.G. M.D. Multiple sclerosis. New Engl J Med 343 (2000) 938-952
13. Brueck W. Clinical implications of neuropathological findings in multiple sclerosis. J Neurol 252 suppl 3 (2005) III10-III14
14. Multiple Sclerosis Therapy Consensus Group (MSTCG). Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations. J Neurol 255 (2008) 1449-1463
15. Weinshenker B.G., O'brian P.C., Petterson T.M., Noseworthy J.H., Lucchinetti C.F., Dodick D.W., Pineda A.A., Stevens L.N., and Rodriguez M. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46 (1999) 878-886
16. Schroeder A., Fischer M., Meyer C., Ellrichmann G., Thoene J., Linker R.A., Chan A., and Gold R. Therapeutic plasma exchange for steroid unresponsive multiple sclerosis relapses - a long-term follow-up observation including 35 patients. Akt Neurol 36 (2009) 105-110
17. Trebst C., Reising A., Kielstein J.T., Hafer C., and Stangel M. Plasma exchange therapy in steroid-unresponsive relapses in patients with multiple sclerosis. Blood Purif 28 (2009) 108-115
18. Wagner D, Kitze B, Klingel R, Bähr M, Müller GA, Koziolek M. Immunoadsorption in 8 multiple sclerosis patients with optic neuritis refractory to corticosteroids. Abstracts of the Annual Meeting of the German Society for Nephrology 2009; abstracts: P130
19. Wenning W., Haghikia A., Laubenberger J., Clifford D.B., Behrens F.B., Chan A., and Gold R. Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab. New Engl J Med 361 (2009) 1075-1080